The ophthalmic drugs market is estimated to be valued at US$ 48.19 Bn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The ophthalmic drugs market comprises drugs used in the treatment of various eye diseases and disorders. The major products include anti-glaucoma drugs, dry eye drugs, retinal ... Read more
